Search - tctmd.com

Displaying 861 - 880 of 1473

Sort: Relevancy | Date

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

News Conference News TCT 2015

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Yael L. Maxwell

October 13, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

News Conference News TCT 2015

INNOVATION Study Suggests Safety of Deferred Stenting

October 13, 2015

News Daily News

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

Todd Neale

October 13, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

October 12, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Opinion Fellow Talk

Researcher Much? A Brief Review of TCT’s Clinical Trial Design and Interpretation Sessions

October 11, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

Advertisement

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

INNOVATION Study Suggests Safety of Deferred Stenting

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Discussion Highlights Merits, Limitations of Small Trials

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Researcher Much? A Brief Review of TCT’s Clinical Trial Design and Interpretation Sessions

Novel Devices Present New Treatment Options for STEMI

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content